Search
for

    Sort by

    Community Join

    90-120 / 1000+ results

      community Dut once a week vs finaster 0.25mg daily? What maintains better?

      in Treatment  5 upvotes 1 month ago
      The user is experiencing increased hair shedding after reducing finasteride to 0.25mg daily and taking dutasteride once a week. They are considering adding KX-826 to their regimen and are seeking advice on whether to increase dutasteride frequency or return to finasteride.

      community Dermastamp or Dermaroller — which one is actually better?

      in Microneedling  8 upvotes 9 months ago
      The conversation discusses the effectiveness of dermastamps versus dermarollers for hair loss treatment, with some users preferring dermastamps for precision and less hair damage. One user reports using a dermastamp with minoxidil, while others mention the convenience of dermapens and the cost-effectiveness of dermarollers.

      community RU58841 vs. KX-826 vs. CB-03-01

       16 upvotes 3 months ago
      RU58841 shows the strongest results despite weaker binding affinity, while KX-826 and CB-03-01 are more expensive and have minimal side effects. RU58841 is considered effective but has potential health risks if ingested; users report positive outcomes with RU58841 and finasteride.

      community 4 months of very inconsistent use

      in Update  11 upvotes 5 months ago
      The user experienced some hair regrowth after 4 months of inconsistent use of topical finasteride and minoxidil, with no noticeable side effects. Others suggest trying oral finasteride and minoxidil for better consistency.

      community Will restarting minoxidil have the same shedding phase as the first time?

      in Minoxidil  5 upvotes 5 months ago
      The user stopped using minoxidil due to scalp issues and switched to finasteride, noticing thicker hair initially but experiencing hair loss again. They are considering restarting minoxidil but are concerned about the shedding phase, especially with upcoming vacation plans and a potential second hair transplant.

      community Topical finasteride vs RU58841 vs KX826

       1 upvotes 1 month ago
      The user is considering switching from topical finasteride to RU58841 or KX826 to reduce side effects but decides to stick with finasteride for now. Users discuss the effectiveness and risks of RU58841 and KX826, with finasteride being considered the most reliable option.

      community long term ru58841 users (3 years+), how is it going for you?

      in Treatment  6 upvotes 1 year ago
      Long-term RU58841 users discuss its effectiveness, with some finding it not worth the cost compared to other treatments like Dutasteride and Minoxidil. One user experienced side effects from a chemical company product, while another is regrowing hair after stopping RU58841.

      community Question about the fin shed

       3 upvotes 10 years ago
      The conversation discusses the effects of stopping and restarting finasteride, including a significant hair shedding phase. The user experienced erection problems with a higher dose and is concerned about whether hair thickness will return after the shedding subsides.

      community KX-826 Phase 3 Failed. Sorry guys...

       51 upvotes 2 years ago
      The conversation discusses the failure of Phase 3 trials for the hair loss treatment KX-826, with no significant difference found between the drug and placebo. Some users express disappointment and skepticism, while others discuss alternative treatments like Minoxidil, finasteride, and RU58841.

      community How often to microneedle for optimal results

      in Microneedling  10 upvotes 1 year ago
      Microneedling for hair loss is discussed, with users suggesting different frequencies and needle lengths, such as 1.5mm every 3 to 6 weeks or 1.0mm weekly. Some users recommend less frequent sessions to avoid scalp damage and soreness.

      community Long term Fin/Min random shed experience

       15 upvotes 9 months ago
      The user experienced significant hair shedding while using finasteride and oral minoxidil but found that the shedding eventually stopped, and hair returned to its previous state. They advise patience, continuing medication, and maintaining good nutrition, including Vitamin D.

      community 2dDR experiment. Seems to be doing something.

       11 upvotes 1 month ago
      A user shared their experience using 2-deoxy-D-ribose (2dDR) for hair regrowth, noting early positive results without side effects, alongside their long-term use of minoxidil and finasteride. They mentioned 2dDR's potential effectiveness in boosting blood flow to hair follicles and its availability online.

      community EdgeLord LLC RU58841 Authenticity?

       3 upvotes 2 years ago
      EdgeLord LLC's RU58841 is discussed for its authenticity and effectiveness in hair loss treatment, with suggestions to dissolve it in Kirkland minoxidil. Users express mixed opinions on the company's legitimacy and product value.

      community Reminder that dermastamps exist and are cheap

      in Microneedling  90 upvotes 4 years ago
      Microneedling, comparing dermarollers and dermastamps as treatments for hair loss, and the effectiveness of each. Dermastamps are considered cheaper than dermapens, but users have varying opinions on which method is more effective with less pain.

      community RU58841 Options in Europe and the UK

       5 upvotes 3 months ago
      The conversation discusses reliable brands for RU58841, with recommendations for RUdirect and Receptorchem. Users also mention Anageninc as a known option for RU58841 in Europe and the UK.

      community Pp405 trials question - 2a/2b,

       6 upvotes 10 months ago
      PP405 trials have completed phase 2a, showing promising results with a 31% stat for hair density increase, and are moving directly to phase 3. Detailed results will be presented at a medical conference in 2026.

      community PP405 2a study was a safety study. Some rational explaining.

       22 upvotes 1 year ago
      The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.